Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant
JAMA Oncology | May 7, 2021 | Volume: 7 | Issue: 7 | Pages: 993
10.1001/jamaoncol.2021.1074
| PMID 33956047